MITOCHONDRIAL RESPIROMETRY IN FROZEN BIOLOGICAL SAMPLES
冷冻生物样品中的线粒体呼吸测定
基本信息
- 批准号:10011475
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-20 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAcuteAgingBiocompatible MaterialsBiologicalBiological AssayBiotechnologyCardiovascular systemCellsClientClinicalClinical ResearchCommunitiesComplexDataDevelopmentDiseaseDrug ExposureEconomicsEnvironmentEnvironmental MonitoringEvaluationFeedbackFreezingFutureGenetic ModelsGoalsHourHumanImpairmentIndustryInstructionLegal patentMeasurementMeasuresMetabolicMethodologyMethodsMitochondriaMitochondrial DiseasesMonitorMusOrganizational ModelsOutcomeOxygen ConsumptionPatientsPharmaceutical PreparationsPharmacologic SubstancePhasePlayPopulationPositioning AttributePreparationProceduresProtocols documentationReagentReproducibilityResearchResearch ContractsResearch PersonnelRespirationRespiratory physiologyRunningSamplingServicesShipsSideSiteSwabTechnologyTechnology AssessmentTestingTimeTissue SampleTissuesToxicant exposureToxicologyUnited States Food and Drug Administrationclinical applicationclinical developmentclinical practiceclinically relevantenvironmental toxicologyimprovedminimally invasivenew technologyrespiratorytoxicant
项目摘要
Abstract
Impaired mitochondrial respiration plays a key role in metabolic, cardiovascular, and aging-related
diseases. However, mitochondrial respirometry analysis currently requires processing of the living tissue
sample within an hour after being taken from the patient. This requirement makes respirometry analysis largely
unfeasible to standard clinical practice and clinical studies. We invented a new technology to assess maximal
mitochondrial respiratory capacity in previously-frozen biological samples, which thus far been considered
impossible by the scientific community. Side-by-side comparison confirmed that our assay accurately reflects
results measured in fresh samples. Our technology thus overcomes the fundamental limitation of standard
approaches that required living tissue. Moreover, our approach consists of simplified sample preparation which
uses significantly less biological material.
Enspire Bio will further develop this patented Frozen Mitos technology to enable respirometry
measurements for clinical applications and frozen samples, which currently is not available. We will achieve
our goals by Aim 1: Establishing standard protocols for oxygen consumption measurements from frozen tissue
samples derived from human and mouse tissue samples. We will further improve throughput by enabling
measurements of oxygen consumption from tissue homogenate instead of isolated mitochondria. Aim 2:
Establishing proprietary kits and delivering those to five beta testing sites including opinion-leading academic
labs, mitochondrial disease centers and a biotech and pharmaceutical company to test and provide feedback.
To provide frozen sample analysis to clients that have no capacity for wet lab assays, we will develop a CRO-
type service in-house where samples will be shipped to EnspireBio for analysis. Working with a set of pilot
academic, clinical and industry clients will provide feedback to establish procedures and the economics of the
CRO model approach for the frozen tissue respirometry.
摘要
线粒体呼吸功能受损在代谢、心血管和衰老相关疾病中起着关键作用。
疾病然而,线粒体呼吸测定分析目前需要处理活组织
在从患者身上采集样本后一小时内。这一要求使得呼吸计量分析在很大程度上
不适用于标准临床实践和临床研究。我们发明了一种新技术来评估
线粒体呼吸能力在以前冷冻的生物样品,迄今为止被认为是
这是科学界不可能的。并排比较证实,我们的分析准确地反映了
在新鲜样品中测量的结果。因此,我们的技术克服了标准
需要活体组织的方法此外,我们的方法包括简化的样品制备,
使用的生物材料要少得多。
Enspire Bio将进一步开发这项专利的冷冻Mitos技术,
用于临床应用和冷冻样品的测量,目前尚不可用。我们将实现
我们的目标1:建立冷冻组织耗氧量测量的标准方案
来自人和小鼠组织样品的样品。我们将进一步提高吞吐量,
测量来自组织匀浆而不是分离的线粒体的氧消耗。目标二:
建立专有的工具包,并将其提供给五个beta测试网站,包括意见领先的学术
实验室、线粒体疾病中心和一家生物技术和制药公司进行测试并提供反馈。
为了向没有湿实验室分析能力的客户提供冷冻样本分析,我们将开发一个CRO-
内部类型服务,样本将运送至EnspireBio进行分析。与一组试点合作
学术,临床和行业客户将提供反馈,以建立程序和经济的
冷冻组织呼吸测定的CRO模型方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Orian S Shirihai其他文献
Cardiac-Specific Fatty Acid Transport Protein 1 (FATP1) Overexpression Causes Decreased Mitochondrial Respiration, Increased Oxidative Stress and Activation of AMPK
- DOI:
10.1016/j.freeradbiomed.2012.10.434 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Aly Elezaby;Edward J Miller;Fuzhong Qin;Marc Liesa;Orian S Shirihai;Wilson S Colucci - 通讯作者:
Wilson S Colucci
Orian S Shirihai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Orian S Shirihai', 18)}}的其他基金
MITOCHONDRIAL RESPIROMETRY IN FROZEN BIOLOGICAL SAMPLES
冷冻生物样品中的线粒体呼吸测定
- 批准号:
10251412 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Role of the heme-related mitochondrial antioxidant ABCB10 in alcoholic liver disease
血红素相关线粒体抗氧化剂 ABCB10 在酒精性肝病中的作用
- 批准号:
10201420 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Role of the heme-related mitochondrial antioxidant ABCB10 in alcoholic liver disease
血红素相关线粒体抗氧化剂 ABCB10 在酒精性肝病中的作用
- 批准号:
10443585 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Mitochondrial dynamics in beta cell function and dysfunction
β细胞功能和功能障碍的线粒体动力学
- 批准号:
7645363 - 财政年份:2007
- 资助金额:
$ 22.5万 - 项目类别:
Mitochondrial dynamics in beta cell function and dysfunction
β细胞功能和功能障碍的线粒体动力学
- 批准号:
8012816 - 财政年份:2007
- 资助金额:
$ 22.5万 - 项目类别:
Mitochondrial dynamics in beta cell function and dysfunction
β细胞功能和功能障碍的线粒体动力学
- 批准号:
7346916 - 财政年份:2007
- 资助金额:
$ 22.5万 - 项目类别:
Mitochondrial dynamics in beta cell function and dysfunction
β细胞功能和功能障碍的线粒体动力学
- 批准号:
7535553 - 财政年份:2007
- 资助金额:
$ 22.5万 - 项目类别:
Mitochondrial dynamics in beta cell function and dysfunction
β细胞功能和功能障碍的线粒体动力学
- 批准号:
7212876 - 财政年份:2007
- 资助金额:
$ 22.5万 - 项目类别:
FUNCTIONAL HETEROGENEITY OF MITOCHONDRIA IN AN INDIVIDUAL PANCREATIC BETA CELL
单个胰腺β细胞中线粒体的功能异质性
- 批准号:
7357321 - 财政年份:2005
- 资助金额:
$ 22.5万 - 项目类别:
相似海外基金
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Aging trajectories and outcomes of older adults with acute myeloid leukemia
患有急性髓性白血病的老年人的衰老轨迹和结果
- 批准号:
10735257 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Centella asiatica effects on neuroinflammatory responses in Drosophila models of acute inflammation and aging
积雪草对果蝇急性炎症和衰老模型神经炎症反应的影响
- 批准号:
10415346 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
Deciphering the impact of aging and inflammation on neurocognitive impairments in people with Post-Acute Sequelae of COVID-19 (PASC)
解读衰老和炎症对患有 COVID-19 急性后遗症 (PASC) 患者神经认知障碍的影响
- 批准号:
460356 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Operating Grants
Effects of Acute Exercise on Functional Magnetic Resonance Spectroscopy Measures of GABA in Aging and Chronic Stroke
急性运动对衰老和慢性中风中 GABA 功能磁共振波谱测量的影响
- 批准号:
10311114 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Acute exercise and the cerebral metabolic response in aging and Alzheimer's Disease
急性运动与衰老和阿尔茨海默病中的大脑代谢反应
- 批准号:
9886905 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Acute exercise and the cerebral metabolic response in aging and Alzheimer's Disease
急性运动与衰老和阿尔茨海默病中的大脑代谢反应
- 批准号:
10551300 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
miRNA Mechanism of Acute Kidney Injury in Aging
衰老过程中急性肾损伤的 miRNA 机制
- 批准号:
9752532 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
miRNA Mechanism of Acute Kidney Injury in Aging
衰老过程中急性肾损伤的 miRNA 机制
- 批准号:
9947747 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
Sedentary Behaviour Interrupted: Acute, medium and long-term effects on biomarkers of healthy aging, physical function and mortality
久坐行为中断:对健康老龄化、身体功能和死亡率的生物标志物的急性、中期和长期影响
- 批准号:
9278020 - 财政年份:2017
- 资助金额:
$ 22.5万 - 项目类别:














{{item.name}}会员




